A synergistic effect between TET2 and RHOA G17V in inducing tumor cell proliferation was discovered in mouse models of AITL with TET2 deletion and RHOA G17V mutation (14, 37). Here, TET2 is linked to angioimmunoblastic T-cell lymphoma.